Article
Identification of Mutations Associated With Macozinone-Resistant in Mycobacterium Tuberculosis.
Current microbiology - 26 May 2022
Chen Xi, Li Yuanyuan, Wang Bin, Lu Yu
Abstract excerpt
Novel anti-tuberculosis drug macozinone (MCZ) is identified as a drug candidate and is currently under clinical development for the treatment of tuberculosis. However, the mutations conferring resistance to MCZ remain inadequately characterized. In this study we investigated resistant mutations to the MCZ through de novo resistance selection in vitro. This was accomplished by passing the Mycobacterium...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
